Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs and Hyaluronic Acid for Wrinkles and Scars
NCT02698813Phase 1Unknown
- Sponsor
- South China Institute for Stem Cell Biology and Regenerative Medicine
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in Wrinkles, acne vulgaris and atrophic scar, sponsored by South China Institute for Stem Cell Biology and Regenerative Medicine. Primary endpoint: Proportion of patients with non-serious and serious adverse events at 12 weeks. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Wrinklesacne vulgarisatrophic scar
Beyond the preview
Go deeper on NCT02698813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698813.